BioCentury
ARTICLE | Financial News

Merck Serono's Israeli incubator debuts two newcos

November 27, 2013 1:10 AM UTC

The Merck Serono Israel Bioincubator debuted two newcos on Tuesday with undisclosed seed financings led by MS Ventures, the strategic corporate fund of the Merck Serono division of Merck KGaA (Xetra:MRK). Metabomed Ltd. (Yavne, Israel) is identifying novel cancer metabolism targets. Boehringer Ingelheim Venture Fund; Pontifax Fund; and Technion Research and Development Foundation also participated in Metabomed's seed financing. ChanBio Ltd. (Yavne, Israel) is discovering functional antibodies that target ion channels, with an initial focus on multiple sclerosis (MS). ...